ArticlePloS one2022

Combination of curaxin and tyrosine kinase inhibitors display enhanced killing of primitive Chronic Myeloid Leukaemia cells.

Stella Pearson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.